Classical and novel forms of multidrug resistance and the physiological functions of P-glycoproteins in mammals

Pharmacology and Therapeutics

Volumn 60, Issue 2, 1993, Pages 289-299

  Borst, P ^a   Schinkel, A H ^a   Smit, J J M ^a   Wagenaar, E ^a   Van Deemter, L ^a   Smith, A J ^a   Eijdems, E W H M ^a   Baas, F ^a   Zaman, G J R ^a  

^a NETHERLANDS CANCER INSTITUTE   (Netherlands)

Author keywords

liver disease; Multidrug resistance; P glycoproteins; steroid metabolism

Indexed keywords

DOXORUBICIN; GLYCOPROTEIN P;

ANIMAL EXPERIMENT; CANCER CHEMOTHERAPY; CONFERENCE PAPER; DRUG METABOLISM; DRUG TRANSPORT; HOMOZYGOSITY; LIVER DISEASE; MOUSE; MULTIDRUG RESISTANCE; MUTATION; NONHUMAN; PRIORITY JOURNAL;

ANIMAL; CARCINOMA, SMALL CELL; CARRIER PROTEINS; DOXORUBICIN; DRUG RESISTANCE; HUMAN; LIVER DISEASES; MEMBRANE GLYCOPROTEINS; MICE; P-GLYCOPROTEIN; STEROIDS; SUPPORT, NON-U.S. GOV'T; TUMOR CELLS, CULTURED;

EID: 0027842835     PISSN: 01637258     EISSN: None     Source Type: Journal    
DOI: 10.1016/0163-7258(93)90011-2     Document Type: Review

References (73)

1. The gene encoding multidrug resistance is induced and expressed at high levels during pregnancy in the secretory epithelium of the uterus
2. Multidrug resistance genes, P-glycoprotein and the liver
3. P-glycoprotein expression is increased in human secretory gestational endometrium
4. A non-P-glycoprotein mediated mechanism for multidrug resistance precedes P-glycoprotein expression during in vitro selection for doxorubicin resistance in a human lung cancer cell line
5. Unknotting the complexities of multidrug resistance: the involvement of DNA topoisomerases in drug action and resistance
6. Mutational analysis of the yeast a-factor transporter STE6, a member of the ATP binding cassette (ABC) protein superfamily
7. Genetic mechanisms of drug resistance
8. Wie Parasiten die Abwehrmechanismen des Körpers überlisten. Robert Koch Lectures
9. Molecular parasitology at Woods Hole
10. The P-glycoprotein gene family
11. Energy metabolism in multidrug resistant tumor cells: a review
12. Coinduction of MDR-1 multidrug-resistance and cytochrome P-450 genes in rat liver by xenobiotics
13. Functional Analysis of chimeric genes obtained by exchanging homologous domains of the mouse mdr1 and mdr2 genes
14. Multidrug resistance in childhood malignancies
15. Structure and expression of the human MDR (P-glycoprotein) gene family
16. Function and regulation of the human multidrug resistance gene
17. Multidrug resistance in small cell lung cancer
18. Overexpression of a transporter gene in a multidrug resistant human lung cancer cell line
19. Multi-drug resistance gene (P-glycoprotein) is expressed by endothelial cells at blood-brain barrier sites
20. Molecular biology of P-glycoprotein
21. The three mouse multidrug resistance (mdr) genes are expressed in a tissue-specific manner in normal mouse tissues
22. Two members of the mouse mdr family confer multidrug resistance with overlapping but distinct drug specificities
23. Genetic transfer of non-P-glycoprotein-mediated multidrug resistance (MDR) in somatic cell fusion: dissection of a compound MDR phenotype
24. Complete cDNA sequences encoding the Chinese hamster P-glycoprotein gene family
25. Multidrug resistance
26. Expression of multidrug-resistance gene in human tumors and tissues
27. Separation of drug transport and chloride channel functions of the human multidrug resistance P-glycoprotein
28. Multidrug resistance in human cancer
29. How cancer cells evade chemotherapy: sisteenth Richard and Hinda Rosenthal Foundation Award Lectures
30. Multidrug resistance: a novel class membrane-associated transport proteins is identified
31. Isolation and expression of a cDNA (mdr) that confers multidrug resistance
32. Cloning and characterization of a second member of the mouse mdr gene family
33. Expression and functional activity of P-glycoprotein in cultured cerebral capillary endothelial cells
34. ABC transporters: from microorganisms to man
35. Is the multidrug transporter a flippase?
36. Multidrug resistance: clinical relevance in hemeatological malignancies
37. Drug resistance, the last frontier?
38. Drug transport variants without P-glycoprotein overexpression from a human squamous lung cancer cell line after selection with doxorubicin
39. Reversal of P-glycoprotein-associated multidrug resistance: the challenge continues
40. P-glycoprotein genes and multidrug resistance
41. The multidrug resistance phenotype of human BRO melanoma cells transfected with a wild-type human mdrl cDNA
42. P-glycoprotein and resistance to anticancer drugs
43. A plasma membrane “Vacuum cleaner” for daunorubicin in P-glycoprotein multidrug resistant SW-1573 human non-small cell lung carcinoma cells A study using fluorescence resonance energy transfer
44. A temperature sensitive topoisomerase II allele confers temperature dependent drug resistance on amsacrine and etoposide: a genetic system for determining the targets of topoisomerase II inhibitors
45. Multidrug resistance (mdr) genes in human cancer
46. Drug resistance and P-glycoprotein gene amplification in the protozoan parasite
47. Functional complementation of yeast ste6 by a mammalian multidrug resistance mdr gene
48. From amplification to function the case of the MDR 1 gene
49. Isolation of human mdr DNA sequences amplified in multidrug-resistant KB carcinoma cells
50. Drug-transporter proteins in clinical multidrug resistance
51. Multidrug resistance mediated by P-glycoproteins
52. Characterization of the human mdr3 P-glycoprotein and its recognition by P-glycoprotein-specific monoclonal antibodies
53. Structure and function of P-glycoprotein
54. Homozygous disruption of the murine mdr 2 P-glycoprotein gene leads to a complete absence of phospholipid from bile to liver disease
55. Platelet-activating factor and related ether lipid mediators
56. Resistance to inhibitors of DNA topoisomerases
57. 1)
58. Functional involvement of P-glycoprotein in blood-brain barrier
59. Overexpression of the multidrug-resistance gene mdr 3 in spontaneous and chemically induced mouse hepatocellular carcinomas
60. Cellularlocalization of the multidrug resistance gene product in normal human tissues
61. MDR1 (P-glycoprotein) gene expression-implications for resistance modifier trials
62. Expression of a full length cDNA for the human MDR 1 gene confers resistance to colchicine, doxorubicin and vinblastine
63. Human P-glycoprotein transports cortisol, aldosterone and dexamethasone, but not progesterone
64. Volume regulated chloride channels associated with the human multidrug-resistance P-glycoprotein
65. The human mdr3 gene encodes a novel P-glycoprotein homologue and gives rise to alternative spliced mRNAs in liver
66. Genes amplified and overexpressed in human multidrug resistant cell lines
67. Sequence of mdr3 cDNA encoding a human P-glycoprotein
68. Multidrug resistance from the clinical point of view
69. Cortisol is transported by the multidrug resistance gene product P-glycoprotein
70. Energy-dependent processes involved in reduced drug accumulation in multidrug-resistant human lung cancer cell lines without P-glycoprotein expression
71. Genistein modulates the decreased drug accumulation in non-P-glycoprotein-mediated multidrug resistant tumor cells
72. P-glycoprotein transports corticosterone and is photoaffinity-labeled by the steroid
73. Analysis of the expression of MRP, the gene for a new putative transmembrane drug transporter, in human multidrug resistant lung cancer cell lines